PROSUS NV (PRX.AS) Fundamental Analysis & Valuation

AMS:PRX • NL0013654783

Current stock price

40.02 EUR
-0.51 (-1.26%)
Last:

This PRX.AS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. PRX.AS Profitability Analysis

1.1 Basic Checks

  • PRX had positive earnings in the past year.
  • In the past year PRX had a positive cash flow from operations.
  • In the past 5 years PRX has always been profitable.
  • The reported operating cash flow has been mixed in the past 5 years: PRX reported negative operating cash flow in multiple years.
PRX.AS Yearly Net Income VS EBIT VS OCF VS FCFPRX.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B

1.2 Ratios

  • The Return On Assets of PRX (16.85%) is better than 91.67% of its industry peers.
  • The Return On Equity of PRX (24.24%) is better than 66.67% of its industry peers.
  • With a Return On Invested Capital value of 0.27%, PRX is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 16.85%
ROE 24.24%
ROIC 0.27%
ROA(3y)14.42%
ROA(5y)16.58%
ROE(3y)20.97%
ROE(5y)23.47%
ROIC(3y)N/A
ROIC(5y)N/A
PRX.AS Yearly ROA, ROE, ROICPRX.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

1.3 Margins

  • PRX has a better Profit Margin (196.38%) than 91.67% of its industry peers.
  • In the last couple of years the Profit Margin of PRX has grown nicely.
  • PRX has a worse Operating Margin (3.87%) than 83.33% of its industry peers.
  • Looking at the Gross Margin, with a value of 45.21%, PRX is in line with its industry, outperforming 41.67% of the companies in the same industry.
  • In the last couple of years the Gross Margin of PRX has grown nicely.
Industry RankSector Rank
OM 3.87%
PM (TTM) 196.38%
GM 45.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.61%
PM growth 5Y12.1%
GM growth 3Y20.87%
GM growth 5Y4.2%
PRX.AS Yearly Profit, Operating, Gross MarginsPRX.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200 300 400

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. PRX.AS Health Analysis

2.1 Basic Checks

  • PRX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, PRX has less shares outstanding
  • Compared to 5 years ago, PRX has more shares outstanding
  • The debt/assets ratio for PRX has been reduced compared to a year ago.
PRX.AS Yearly Shares OutstandingPRX.AS Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B
PRX.AS Yearly Total Debt VS Total AssetsPRX.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • PRX has an Altman-Z score of 3.91. This indicates that PRX is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of PRX (3.91) is better than 66.67% of its industry peers.
  • The Debt to FCF ratio of PRX is 9.30, which is on the high side as it means it would take PRX, 9.30 years of fcf income to pay off all of its debts.
  • PRX's Debt to FCF ratio of 9.30 is in line compared to the rest of the industry. PRX outperforms 41.67% of its industry peers.
  • PRX has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
  • PRX's Debt to Equity ratio of 0.30 is fine compared to the rest of the industry. PRX outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 9.3
Altman-Z 3.91
ROIC/WACC0.03
WACC8.04%
PRX.AS Yearly LT Debt VS Equity VS FCFPRX.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B 30B 40B 50B

2.3 Liquidity

  • PRX has a Current Ratio of 3.66. This indicates that PRX is financially healthy and has no problem in meeting its short term obligations.
  • PRX's Current ratio of 3.66 is amongst the best of the industry. PRX outperforms 91.67% of its industry peers.
  • PRX has a Quick Ratio of 3.62. This indicates that PRX is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 3.62, PRX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.66
Quick Ratio 3.62
PRX.AS Yearly Current Assets VS Current LiabilitesPRX.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. PRX.AS Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 87.14% over the past year.
  • The Earnings Per Share has been growing by 17.24% on average over the past years. This is quite good.
  • The Revenue has grown by 16.28% in the past year. This is quite good.
  • PRX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.13% yearly.
EPS 1Y (TTM)87.14%
EPS 3Y-3.39%
EPS 5Y17.24%
EPS Q2Q%35.96%
Revenue 1Y (TTM)16.28%
Revenue growth 3Y-0.36%
Revenue growth 5Y13.13%
Sales Q2Q%22.27%

3.2 Future

  • Based on estimates for the next years, PRX will show a quite strong growth in Earnings Per Share. The EPS will grow by 11.73% on average per year.
  • PRX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.04% yearly.
EPS Next Y28.2%
EPS Next 2Y23.26%
EPS Next 3Y20.67%
EPS Next 5Y11.73%
Revenue Next Year34.91%
Revenue Next 2Y31.59%
Revenue Next 3Y26.2%
Revenue Next 5Y16.04%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PRX.AS Yearly Revenue VS EstimatesPRX.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
PRX.AS Yearly EPS VS EstimatesPRX.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

7

4. PRX.AS Valuation Analysis

4.1 Price/Earnings Ratio

  • PRX is valuated cheaply with a Price/Earnings ratio of 7.89.
  • Compared to the rest of the industry, the Price/Earnings ratio of PRX indicates a rather cheap valuation: PRX is cheaper than 91.67% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of PRX to the average of the S&P500 Index (26.17), we can say PRX is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 9.24, the valuation of PRX can be described as reasonable.
  • 91.67% of the companies in the same industry are more expensive than PRX, based on the Price/Forward Earnings ratio.
  • PRX is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.05, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.89
Fwd PE 9.24
PRX.AS Price Earnings VS Forward Price EarningsPRX.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PRX is valued more expensive than 91.67% of the companies in the same industry.
  • PRX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 57.42
EV/EBITDA 294.51
PRX.AS Per share dataPRX.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • PRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • PRX's earnings are expected to grow with 20.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.28
PEG (5Y)0.46
EPS Next 2Y23.26%
EPS Next 3Y20.67%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. PRX.AS Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.52%, PRX is not a good candidate for dividend investing.
  • The stock price of PRX dropped by -25.61% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • Compared to an average industry Dividend Yield of 0.63, PRX pays a bit more dividend than its industry peers.
  • With a Dividend Yield of 0.52, PRX pays less dividend than the S&P500 average, which is at 1.89.
Industry RankSector Rank
Dividend Yield 0.52%

5.2 History

  • The dividend of PRX decreases each year by -19.73%.
Dividend Growth(5Y)-19.73%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • 2.00% of the earnings are spent on dividend by PRX. This is a low number and sustainable payout ratio.
DP2%
EPS Next 2Y23.26%
EPS Next 3Y20.67%
PRX.AS Yearly Income VS Free CF VS DividendPRX.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B
PRX.AS Dividend Payout.PRX.AS Dividend Payout, showing the Payout Ratio.PRX.AS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

PRX.AS Fundamentals: All Metrics, Ratios and Statistics

PROSUS NV

AMS:PRX (4/2/2026, 7:00:00 PM)

40.02

-0.51 (-1.26%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)11-24
Earnings (Next)N/A
Inst Owners64.94%
Inst Owner ChangeN/A
Ins Owners0.75%
Ins Owner ChangeN/A
Market Cap95.21B
Revenue(TTM)6.83B
Net Income(TTM)13.41B
Analysts81.67
Price Target67.72 (69.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.52%
Yearly Dividend0.04
Dividend Growth(5Y)-19.73%
DP2%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.09%
PT rev (3m)0.18%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)7.11%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.35%
Revenue NY rev (3m)2.33%
Valuation
Industry RankSector Rank
PE 7.89
Fwd PE 9.24
P/S 16.07
P/FCF 57.42
P/OCF 54.48
P/B 1.98
P/tB 2.13
EV/EBITDA 294.51
EPS(TTM)5.07
EY12.67%
EPS(NY)4.33
Fwd EY10.82%
FCF(TTM)0.7
FCFY1.74%
OCF(TTM)0.73
OCFY1.84%
SpS2.49
BVpS20.18
TBVpS18.78
PEG (NY)0.28
PEG (5Y)0.46
Graham Number47.99
Profitability
Industry RankSector Rank
ROA 16.85%
ROE 24.24%
ROCE 0.36%
ROIC 0.27%
ROICexc 0.29%
ROICexgc 0.3%
OM 3.87%
PM (TTM) 196.38%
GM 45.21%
FCFM 27.98%
ROA(3y)14.42%
ROA(5y)16.58%
ROE(3y)20.97%
ROE(5y)23.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.61%
PM growth 5Y12.1%
GM growth 3Y20.87%
GM growth 5Y4.2%
F-Score7
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 9.3
Debt/EBITDA 40.19
Cap/Depr 70.55%
Cap/Sales 1.51%
Interest Coverage 0.46
Cash Conversion 491.22%
Profit Quality 14.25%
Current Ratio 3.66
Quick Ratio 3.62
Altman-Z 3.91
F-Score7
WACC8.04%
ROIC/WACC0.03
Cap/Depr(3y)83.48%
Cap/Depr(5y)79.69%
Cap/Sales(3y)2.75%
Cap/Sales(5y)2.9%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.14%
EPS 3Y-3.39%
EPS 5Y17.24%
EPS Q2Q%35.96%
EPS Next Y28.2%
EPS Next 2Y23.26%
EPS Next 3Y20.67%
EPS Next 5Y11.73%
Revenue 1Y (TTM)16.28%
Revenue growth 3Y-0.36%
Revenue growth 5Y13.13%
Sales Q2Q%22.27%
Revenue Next Year34.91%
Revenue Next 2Y31.59%
Revenue Next 3Y26.2%
Revenue Next 5Y16.04%
EBIT growth 1Y576.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year372.25%
EBIT Next 3Y107.05%
EBIT Next 5Y139.61%
FCF growth 1Y289.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y217.17%
OCF growth 3YN/A
OCF growth 5YN/A

PROSUS NV / PRX.AS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for PROSUS NV?

ChartMill assigns a fundamental rating of 6 / 10 to PRX.AS.


What is the valuation status of PROSUS NV (PRX.AS) stock?

ChartMill assigns a valuation rating of 7 / 10 to PROSUS NV (PRX.AS). This can be considered as Undervalued.


How profitable is PROSUS NV (PRX.AS) stock?

PROSUS NV (PRX.AS) has a profitability rating of 5 / 10.


What are the PE and PB ratios of PROSUS NV (PRX.AS) stock?

The Price/Earnings (PE) ratio for PROSUS NV (PRX.AS) is 7.89 and the Price/Book (PB) ratio is 1.98.


What is the financial health of PROSUS NV (PRX.AS) stock?

The financial health rating of PROSUS NV (PRX.AS) is 7 / 10.